Eckert & Ziegler SE Shareholders Approve 29% Dividend Increase for 2025

Eckert & Ziegler SE (ISIN DE0005659700) announced today that its Annual General Meeting, held as an in-person event near the company’s Berlin headquarters, approved a dividend of EUR 0.22 per share for the 2025 fiscal year, up from EUR 0.17 in the previous year. The 29% increase underscores the company’s robust financial health and its dedication to rewarding shareholders.

The meeting, which saw 55.37% of the company’s share capital represented, endorsed the actions of the Executive Board and Supervisory Board for fiscal 2025 and passed all agenda items by a large majority. The detailed voting results and the CEO’s presentation are available on the company’s website at https://www.ezag.com/investors/annual-general-meeting/.

Eckert & Ziegler SE, a leading specialist in isotope-related components for nuclear medicine and radiation therapy, employs over 1,000 people. The company provides a comprehensive range of services and products for the radiopharmaceutical industry, spanning early development to contract manufacturing and distribution. Its shares are listed in the TecDAX index of Deutsche Börse.

The dividend increase signals confidence in the company’s ongoing growth trajectory and its ability to generate value for investors. This move is particularly significant given the critical role Eckert & Ziegler plays in the healthcare sector, contributing to life-saving medical procedures through its innovative isotope technologies.

For more information, investors can access the full meeting documentation on the company’s investor relations page.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Eckert & Ziegler SE Shareholders Approve 29% Dividend Increase for 2025.

The post Eckert & Ziegler SE Shareholders Approve 29% Dividend Increase for 2025 appeared first on citybuzz.